date,title,source
Oct-18-18,Can UnitedHealth Group and Johnson & Johnson Continue Their Winning Ways?,Motley Fool
Oct-18-18,Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-18-18,Risk-Reward With Gilead Sciences,GuruFocus.com
Oct-18-18,Edited Transcript of GILD earnings conference call or presentation 25-Jul-18 9:00pm GMT,Thomson Reuters StreetEvents
Oct-18-18,"Market Morning: China, Yuan Crushed; Fed Minutes Sparse, HIV Meets Match, Exxon Wants China",Market Exclusive
Oct-18-18,Is Sangamo Therapeutics Inc. a Buy?,Motley Fool
Oct-19-18,Jackpot stocks that could make you a billionaire,CNBC Videos
Oct-19-18,Could a Diagnostic Be Key to Winning This Big Healthcare Market?,Motley Fool
Oct-19-18,Investors Hunt for Biotech Winners as Wider Stock Market Churns,Bloomberg
Oct-22-18,Will Gilead (GILD) HIV Sales Offset HCV Sales Decline in Q3?,Zacks
Oct-22-18,POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET,GlobeNewswire
Oct-22-18,Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet,Business Wire
Oct-23-18,Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today,Motley Fool
Oct-23-18,"Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook",Zacks
Oct-23-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",Zacks
Oct-24-18,3 Top Healthcare Stocks to Buy Right Now,Motley Fool
Oct-24-18,Gilead earnings: Expect a strong quarter despite executive turnover,MarketWatch
Oct-24-18,Healthcare ETFs to Buy Ahead of Q3 Earnings,Zacks
Oct-24-18,Investors Are Underestimating Gilead Sciences Stock,InvestorPlace
Oct-24-18,"Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",Zacks
Oct-25-18,"Gilead hepatitis C drug sales fall, but profit beats estimates",Reuters
Oct-25-18,"UPDATE 1-Gilead hepatitis C drug sales fall, but profit beats estimates",Reuters
Oct-25-18,Gilead 3rd quarter profit falls as hepatitis C drug sales wane,Reuters
Oct-25-18,Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates,Zacks
Oct-25-18,Gilead's stock gains on better-than-expected earnings,MarketWatch
Oct-25-18,"Gilead Beats Third-Quarter Sales, Adjusted Profit Views",Investor's Business Daily
Oct-25-18,Gilead Sciences Announces Fourth Quarter 2018 Dividend,Business Wire
Oct-25-18,Gilead Sciences Announces Third Quarter 2018 Financial Results,Business Wire
Oct-25-18,"Gilead Sciences beats earnings, revenues expectations",CNBC Videos
Oct-25-18,Gilead earnings: Expect a strong quarter despite executive turnover,MarketWatch
Oct-25-18,A Preview Of Gilead's Q3 Earnings,Benzinga
Oct-26-18,Gilead Sciences Stock Is Back to Base  Go Long,InvestorPlace
Oct-26-18,Gilead Sciences Stock Divides Analysts After Earnings Report,Barrons.com
Oct-26-18,"Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View",Zacks
Oct-26-18,"[$$] Stocks to Watch: Amazon, Alphabet, Intel, Chipotle, Snap, Expedia",The Wall Street Journal
Oct-26-18,The bigger message behind Amgens decision to slash cost of its Repatha cholesterol drug,MarketWatch
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-26-18,"Today's Research Reports on Trending Tickers: Gilead Sciences, Inc. and Esperion Therapeutics, Inc.",ACCESSWIRE
Oct-26-18,"Gilead Sciences' 3rd Quarter: Good News Gets Better, Bad News Gets Worse",Motley Fool
Oct-26-18,Gilead Sciences Inc (GILD) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-26-18,Edited Transcript of GILD earnings conference call or presentation 25-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Edited Transcript of GILD earnings conference call or presentation 25-Oct-18 8:30pm GMT,Thomson Reuters StreetEvents
Oct-29-18,Gilead Sciences (GILD) Gains As Market Dips: What You Should Know,Zacks
Oct-29-18,"Gilead charged $1,100 a day for this drug. Now it will launch a generic at quarter the price.",American City Business Journals
Oct-29-18,Dr. Reddy's (RDY) Earnings and Revenues Improve Y/Y in Q2,Zacks
Oct-29-18,7 Rising Healthcare Stocks to Consider,InvestorPlace
Oct-29-18,The bigger message behind Amgens decision to slash cost of its Repatha cholesterol drug,MarketWatch
Oct-29-18,Be Ready to Ride the Dividend on Gilead Sciences,TheStreet.com
Oct-29-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)",Zacks
Oct-31-18,Jerome Dodson Comments on Gilead Sciences,GuruFocus.com
Oct-31-18,Gilead shares drop after new UnitedHealth program incentivizes cheaper HIV meds,MarketWatch
Oct-31-18,Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies,Business Wire
Oct-31-18,"Investor Expectations to Drive Momentum within Gilead Sciences, SCANA, Brink's, Fortive, Asbury Automotive Group, and Helmerich & Payne  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-31-18,"Market Morning: Record Down Days, Biotech Buyback Busts, Coke Raising Prices, Credit Tightens",Market Exclusive
Nov-01-18,Biotech ETFs in Focus on String of Q3 Earnings Beat,Zacks
Nov-01-18,Gilead to Present Latest Scientific Research in Hematologic Malignancies and Solid Tumors at ASH 2018,Business Wire
Nov-01-18,"3 Big Stock Charts for Thursday: Walmart, Prologis and Incyte",InvestorPlace
Nov-01-18,Today's Research Reports on Trending Tickers: Gilead Sciences and BeiGene,ACCESSWIRE
Nov-01-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Amgen, Vertex Pharmaceuticals, Celgene and Regeneron Pharmaceuticals",Zacks
Nov-05-18,Exclusive: Small Peninsula city rejects developer's housing plan  and tells it to go bigger,American City Business Journals
Nov-05-18,"Why Gilead Sciences, Inc. Stock Broke Down in October",Motley Fool
Nov-08-18,Is Gilead Sciences Incs (NASDAQ:GILD) Balance Sheet Strong Enough To Weather A Storm?,Simply Wall St.
Nov-08-18,Biotech stocks have been hit hard  here are ones analysts like best for a rebound,MarketWatch
Nov-08-18,East Bay biotech scores $42 million with potential quick-fix for heart trouble,American City Business Journals
Nov-08-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-12-18,"Gilead Sciences to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27",Business Wire
Nov-13-18,Express Scripts offers new formulary for lower list-price drugs,Reuters
Nov-14-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-14-18,"Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges",Zacks
Nov-15-18,BeiGene (BGNE) Catches Eye: Stock Jumps 8.3%,Zacks
Nov-19-18,Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta,Zacks
Nov-19-18,Tesaro Stock Sinks in Aftermath of Sale Rumors,InvestorPlace
Nov-19-18,Amgen's Blincyto Gets Positive CHMP Opinion for Line Extension,Zacks
Nov-20-18,Gilead's Vemlidy Gets Approval in China for HBV Infection,Zacks
Nov-20-18,Emergent's (EBS) Zika Vaccine Candidate Meets Study Endpoint,Zacks
Nov-21-18,"Biotech Stock Roundup: GILD's Drug Wins Nod in China, Arena Up On Licensing Deal",Zacks
Nov-21-18,Should Value Investors Consider Gilead (GILD) Stock Now?,Zacks
Nov-23-18,Novartis Gets Approval for Gene Therapy Luxturna in Europe,Zacks
Nov-26-18,"Health Care Digest: Genentech's blood cancer win, a boost for Gilead's HIV PrEP and a tiny IPO swings at antibiotics",American City Business Journals
Nov-26-18,"Gilead's HIV Franchise, CAR T Therapy Likely to Propel Growth",Zacks
Nov-27-18,Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial,Zacks
Nov-27-18,"Alnylam, Vir Begin Phase I/II Study on Hepatitis B Candidate",Zacks
Nov-27-18,Bristol-Myers' Opdivo-Yervoy Combo Fails in Lung Cancer Trial,Zacks
Nov-27-18,Roche buys U.S. biotech Jecure in race for liver disease drugs,Reuters
Nov-27-18,5 Biotech Stocks to Scoop Up for Big Dividends,InvestorPlace
Nov-27-18,Eyenovia Initiates Phase III Study for Mydriasis Candidate,Zacks
Nov-27-18,Bayer's TRK Inhibitor Gets FDA Nod for Advanced Solid Tumors,Zacks
Nov-27-18,"Wall Street Wants the Best Patents, Not the Best Drugs",Bloomberg
Nov-28-18,Novartis (NVS) Receives EC Approval for Neulasta Biosimilar,Zacks
Nov-28-18,Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity,Zacks
Nov-28-18,Celgene & Bluebird's CAR T Therapy Study Completes Enrollment,Zacks
Nov-28-18,Aileron Inks Collaboration Deal With Pfizer for Cancer Combo,Zacks
Nov-29-18,Merck (MRK) Receives Approval for 2 HIV Medicines in EU,Zacks
Nov-29-18,Roche (RHHBY) to Acquire Jecure and Enter the NASH Space,Zacks
Nov-29-18,Catalyst's Firdapse Receives FDA Approval for Rare Disease,Zacks
Nov-30-18,3 Top Dividend Stocks With Yields Over 3%,Motley Fool
Nov-30-18,This Biotech Stock Could Launch Its First CRISPR Drug In 2022,Investor's Business Daily
Nov-30-18,Key Pharma Players With HIV Focus Ahead of World Aids Day,Zacks
Nov-30-18,Bayer (BAYRY) to Restructure Business & Reduce Headcount,Zacks
Dec-03-18,Kite Announces Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia,Business Wire
Dec-03-18,Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know,Zacks
Dec-03-18,UPDATE 1-High-cost Gilead cell therapy proves durable for some lymphoma patients,Reuters
Dec-03-18,Shire's Takhzyro Gets European Nod for Hereditary Angioedema,Zacks
Dec-03-18,FDA Committee to Review Amgen's (AMGN) Osteoporosis Candidate,Zacks
Dec-04-18,Amgen's BiTE Immunotherapies Show Promise in Early Studies,Zacks
Dec-04-18,Gilead (GILD) Announces Data on CAR T Therapy Candidate,Zacks
Dec-07-18,CEO of Chapel Hill firm talks 2 new partnerships with big pharma,American City Business Journals
Dec-07-18,"Hedge Funds Are Dumping Gilead Sciences, Inc. (GILD)",Insider Monkey
Dec-10-18,Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know,Zacks
Dec-10-18,Health Care Digest: Where were the women in Gilead's CEO search  and more,American City Business Journals
Dec-10-18,Gilead Sciences Names Roche's O'Day as CEO and Chairman,TheStreet.com
Dec-10-18,Gilead Needs More Than a Steady Hand From Its New CEO,Bloomberg
Dec-10-18,Roche's Tecentriq Gets FDA Approval for First-Line NSCLC,Zacks
Dec-10-18,[$$] Gilead Looks Outside to Revive Growth,The Wall Street Journal
Dec-10-18,Dont Punish Gilead Stock for Doing Its Job,InvestorPlace
Dec-10-18,"Stocks - Apple, Boeing Slip in Premarket; Gilead Sciences, Tesla, Amazon Rise",Investing.com
Dec-10-18,"Stocks Mixed, Dow Jones Dips As China Locks Apple Sales",Investor's Business Daily
Dec-10-18,"Gilead Gains, FedEx Falls and 5 More Morning Movers",Barrons.com
Dec-10-18,"Elon Musk, Carlos Ghosn, Huawei and Gilead Sciences - 5 Things You Must Know",TheStreet.com
Dec-10-18,"New Research Coverage Highlights Skyworks Solutions, Virtus Investment Partners, Altria Group, Gilead Sciences, Arthur J. Gallagher, and BP p.l.c  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-10-18,[$$] US drugmaker Gilead poaches Roche executive Daniel ODay,Financial Times
Dec-10-18,Roche vet named Gilead CEO  and Genentech boss moves to Switzerland  in shuffle of top Bay Area biotech execs,American City Business Journals
Dec-10-18,Struggling Gilead Taps Roche Executive as New CEO,The Wall Street Journal
Dec-10-18,Gilead Sciences snares Roche executive O'Day as CEO,Reuters
Dec-10-18,Gilead Sciences snares Roche executive O'Day as CEO,Reuters
Dec-10-18,Gilead Sciences Names Daniel ODay Chairman and Chief Executive Officer,Business Wire
Dec-11-18,Gilead Sciences (GILD) Appoints Daniel O'Day as New CEO,Zacks
Dec-11-18,"New Gilead Sciences CEO Has 'Breadth Of Experience' From Time At Roche, Says Bullish Raymond James",Benzinga
Dec-11-18,The 10 Best Marijuana Stocks to Buy in 2019,InvestorPlace
Dec-11-18,4 Biotech Stocks Investors Can Add to Their Portfolio in 2019,Zacks
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-12-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen",Zacks
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-13-18,Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals,Zacks
Dec-14-18,Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus,Zacks
Dec-14-18,AMAG to Acquire Ciraparantag Maker Perosphere Pharmaceuticals,Zacks
Dec-14-18,5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride,Zacks
Dec-14-18,Today's Research Reports on Trending Tickers: Axovant Sciences and Gilead Sciences,ACCESSWIRE
Dec-17-18,Gilead Sciences (GILD) Stock Moves -0.69%: What You Should Know,Zacks
Dec-17-18,5 Healthcare Stocks That Are Feeling Sick,InvestorPlace
Dec-17-18,7 Major Pharmaceutical Stocks to Quarantine Now,InvestorPlace
Dec-18-18,Bristol-Myers' Label Expansion of Sprycel Gets CHMP Nod,Zacks
Dec-18-18,Evofem Shares Up as Birth Control Gel Succeeds in Phase III,Zacks
Dec-18-18,Biotech Stocks Gilead Sciences and Biogen Have Room to Bounce Back,Barrons.com
Dec-18-18,Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer,Zacks
Dec-18-18,What Happened With CAR-T Stocks in 2018,Motley Fool
Dec-18-18,3 Biotechs With Potential Blockbusters Near the Finish Line,Motley Fool
Dec-19-18,Vertex's (VRTX) 3rd Study on Pain Drug Meets Primary Endpoint,Zacks
Dec-19-18,"Forget bluebird bio, Amgen Is a Better Biotech Stock",Motley Fool
Dec-19-18,Gilead Sciences and Scholar Rock Announce Strategic Collaboration to Develop Novel Therapies for Fibrotic Diseases,Business Wire
Dec-20-18,Why Agenus Stock Is Soaring Today,Motley Fool
Dec-20-18,Raymond James: Gilead In NASH For The Long Haul,Benzinga
Dec-20-18,Agenus stock shoots up 60% after announcing drug development deal with Gilead,MarketWatch
Dec-20-18,"Gilead, Agenus sign deal to develop immuno-oncology therapies",Reuters
Dec-20-18,Gilead And Agenus Enter into Collaboration to Develop Immuno-Oncology Therapies,PR Newswire
Dec-20-18,Gilead and Agenus Enter Into Collaboration to Develop Immuno-Oncology Therapies,Business Wire
Dec-20-18,Biotech Stocks Set to Breakout,ACCESSWIRE
Dec-21-18,Agenus' Stock Up 23% on Immuno-Oncology Deal With Gilead,Zacks
Dec-21-18,Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer,Zacks
Dec-21-18,Major Biotech Deals Making Sector Red Hot,ACCESSWIRE
Dec-24-18,The 9 Best Stocks of Americas Last Bear Market,Kiplinger
Dec-24-18,"Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more",American City Business Journals
Dec-24-18,Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III,Zacks
Dec-24-18,Alexion's Ultomiris Gets Early FDA Nod for Rare Blood Disorder,Zacks
Dec-24-18,Acorda Gets FDA Approval for Parkinson's Disease Drug Inbrija,Zacks
Dec-24-18,Immunomedics (IMMU) in Focus: Stock Moves 6.1% Higher,Zacks
Dec-26-18,3 Biotech Stocks That Are Too Cheap to Ignore,Motley Fool
Dec-26-18,"Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal",Zacks
Dec-28-18,Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know,Zacks
Dec-28-18,Intercept (ICPT) Benefits from Ocaliva's Recovery in 2018,Zacks
Dec-28-18,2019 biotech preview: Money is pouring into the Bay Area and so is Big Pharma,American City Business Journals
Jan-02-19,"Gilead Sciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7",Business Wire
Jan-02-19,Biotech Rally Ahead of the Market,ACCESSWIRE
Jan-03-19,Factbox - Bristol-Myers' $74 billion Celgene buy has investors looking for next deal,Reuters
Jan-03-19,Gilead Stock Breaks Out to Channel Resistance,Investopedia
Jan-03-19,3 Biopharma Stocks to Buy for Their Robust Dividend Yields,InvestorPlace
Jan-03-19,Gilead Sciences Gets a Boost After Celgene Deal,Barrons.com
Jan-03-19,"Stocks Tumble, Celgene Spikes; Apple Cripples Global Tech Stocks",Investor's Business Daily
Jan-04-19,Today's Research Reports on Trending Tickers: Prana Biotechnology and Gilead Sciences,ACCESSWIRE
Jan-07-19,Gilead Sciences (GILD) Gains But Lags Market: What You Should Know,Zacks
Jan-07-19,"Biotech's big conference living up to reputation with big deals, big costs",American City Business Journals
Jan-07-19,Why Agenus Stock Is Spiking Today,Motley Fool
Jan-07-19,"As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock",InvestorPlace
Jan-07-19,Merck loses bid to revive $200 million Gilead verdict at U.S. high court,Reuters
Jan-07-19,Merck loses bid to revive $200 million Gilead verdict at U.S. high court,Reuters
Jan-07-19,Merck loses bid to revive $200 mln Gilead verdict at U.S. high court,Reuters
Jan-07-19,Gilead (GILD) Collaborates With Yuhan for NASH Candidates,Zacks
Jan-08-19,The 9 Best Stocks of America&rsquo;s Last Bear Market,Kiplinger
Jan-08-19,"Top Gainers: Union Pacific, Motorcar Parts, Nektar Rally Into Close",Investing.com
Jan-08-19,7 Things to Expect for Gilead Sciences in 2019,Motley Fool
Jan-09-19,"Have Insiders Been Selling Gilead Sciences, Inc. (NASDAQ:GILD) Shares?",Simply Wall St.
Jan-09-19,Value Added: 7 Top Stocks for 2019,Kiplinger
Jan-09-19,"Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus",Zacks
Jan-09-19,Cell therapy pioneer eyes Bay Area manufacturing,American City Business Journals
Jan-11-19,Here's Why Verastem Tumbled 34.1% in December,Motley Fool
Jan-11-19,NASH Space in Focus in 2019 as Firms Look to Diversify,Zacks
Jan-15-19,Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know,Zacks
Jan-15-19,Here's How The Government Shutdown Will Affect These Medical Stocks,Investor's Business Daily
Jan-16-19,Will Dividend Stocks be the Hot Stocks of 2019?,Zacks
Jan-17-19,1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet),Motley Fool
Jan-17-19,Why Gilead Sciences Stock Sank by 12.7% in 2018,Motley Fool
Jan-17-19,"Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&amp;T and Verizon",Zacks
Jan-18-19,These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts,Investor's Business Daily
Jan-18-19,Searching For A Treatment: NASH Investigational Drugs With Catalysts This Year,Benzinga
Jan-22-19,"Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019",Business Wire
